ArticleSurgical infections2026
Outcomes and Predictors of Fungal Necrotizing Soft Tissue Infections.
Article in Surgical infections, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
Abstract
introductionFungal necrotizing soft tissue infections (NSTIs) are often diagnosed late due to the low likelihood, resulting in poor patient outcomes. Traditionally NSTI are treated with emergent surgical debridement followed by serial interventions. Adjunctive antibiotics are aimed at common bacterial infections along with toxin reduction; however, fungal treatment is often delayed. This study aimed to identify predictors, treatment patterns, and outcomes in fungal NSTIs.
methodsA retrospective review of patients with NSTIs (n = 634) from a single tertiary academic center was conducted from 2011 to 2023, with patients stratified by fungal presence in wound cultures. Primary outcomes were mortality along with the number of serial debridement. Secondary outcomes were length of stay, intensive care requirements, acute kidney injury, and 30-days readmission. Logistic regression was utilized to identify predictors of fungal infection.
resultsOf 634 patients, 110 (17.4%) had fungal-positive wound cultures, with
conclusionFungal NSTIs are associated with worse patient outcomes. Early empirical antifungal therapy may be considered in high-risk patients, particularly those with diabetes, as part of comprehensive NSTI management.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.